Besides acting as a downstream factor of HIF1, C-MYC has a synergistic effect with HIF-1 on inducing glycolysis by promoting 3-phosphoinositide dependent kinase-1 and HK2 and inducing angiogenesis, leading to hypoxia adaptation, internal environment stability, and chemoresistance in cancer (202, 203). This evidence concerns the gene MYC and cancer.